NOS-2 Mediates the Protective Anti-Inflammatory and Antifibrotic Effects of the Th1-Inducing Adjuvant, IL-12, in a Th2 Model of Granulomatous Disease
- 30 September 2000
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 157 (3), 945-955
- https://doi.org/10.1016/s0002-9440(10)64607-x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammationJCI Insight, 1999
- An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2–dominated inflammatory responseJCI Insight, 1999
- The role of nitric oxide in sepsis – an overviewActa Anaesthesiologica Scandinavica, 1999
- Other Functions, Other Genes: Alternative Activation of Antigen-Presenting CellsImmunity, 1999
- Collagen Deposition in a Non-Fibrotic Lung Granuloma Model after Nitric Oxide InhibitionThe American Journal of Pathology, 1998
- NITRIC OXIDE AND MACROPHAGE FUNCTIONAnnual Review of Immunology, 1997
- The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.The Journal of Experimental Medicine, 1996
- Altered immune responses in mice lacking inducible nitric oxide synthaseNature, 1995
- The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.The Journal of Experimental Medicine, 1994
- Suppression of arthritis by an inhibitor of nitric oxide synthase.The Journal of Experimental Medicine, 1993